Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 12/20 | 0.37 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PI4KA | P42356 | 1/20 | 0.32 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22845390 | 0.98 | ALOX5 (0.42) | ALOX5LIMK1PRKDCLIMK2PIK3CA | |
| SCHEMBL22845440 | 0.93 | ALOX5 (0.44) | ALOX5LIMK1PRKDCPIK3CAMAPK14 | |
| SCHEMBL22329476 | 0.92 | ALOX5 (0.38) | ALOX5LIMK1PRKDCLIMK2PIK3CA | |
| SCHEMBL22845242 | 0.92 | ALOX5 (0.48) | ALOX5LIMK1PRKDCPIK3CA | |
| SCHEMBL22329968 | 0.92 | LIMK1 (0.36) | ALOX5LIMK1PRKDCLIMK2PIK3CA | |
| SCHEMBL22845410 | 0.91 | ALOX5 (0.39) | ALOX5LIMK1PRKDCADORA2AADORA1 | |
| SCHEMBL22700435 | 0.91 | ALOX5 (0.38) | ALOX5LIMK1PRKDCLIMK2MAPK14 | |
| SCHEMBL22329970 | 0.91 | ALOX5 (0.38) | ALOX5LIMK1PRKDCLIMK2MAPK14 | |
| SCHEMBL22845247 | 0.91 | LIMK1 (0.38) | ALOX5LIMK1PRKDCMAPK14ADORA2A | |
| SCHEMBL24303469 | 0.91 | ALOX5 (0.45) | ALOX5LIMK1PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200407348-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2020-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407348-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OXER1, OCIAD2 | ALOX5 285/4885LIMK1 96/4885PRKDC 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.